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Background: Spirometry testing is essential to confirm an obstructive lung disease, but studies have reported that
a large proportion of patients diagnosed with COPD or asthma have no history of spirometry testing. Also, it has
been shown that many patients are prescribed medication for obstructive lung disease without a relevant diagnosis
or spirometry test registered. General practice characteristics have been reported to influence diagnosis and
management of several chronic diseases. However, these findings are inconsistent, and it is uncertain whether
practice characteristics influence spirometry testing among patients receiving medication for obstructive lung
disease. The aim of this study was therefore to examine if practice characteristics are associated with spirometry
testing among patients receiving first-time prescriptions for medication targeting obstructive lung disease.
Methods: A national register-based cohort study was performed. All patients over 18 years receiving first-time
prescriptions for medication targeting obstructive lung disease in 2008 were identified and detailed patient-specific
data on sociodemographic status and spirometry tests were extracted. Information on practice characteristics like
number of doctors, number of patients per doctor, training practice status, as well as age and gender of the
general practitioners was linked to each medication user.
Results: Partnership practices had a higher odds ratio (OR) of performing spirometry compared with single-handed
practices (OR 1.24, CI 1.09-1.40). We found a significant association between increasing general practitioner age and
decreasing spirometry testing. This tendency was most pronounced among partnership practices, where doctors
over 65 years had the lowest odds of spirometry testing (OR 0.25, CI 0.10-0.61). Training practice status was
significantly associated with spirometry testing among single-handed practices (OR 1.40, CI 1.10-1.79).
Conclusion: Some of the variation in spirometry testing among patients receiving first-time prescriptions for
medication targeting obstructive lung disease was associated with practice characteristics. This variation in
performance may indicate a potential for quality improvement.
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Spirometry is recommended for diagnosis and manage-
ment of obstructive lung diseases like asthma and chronic
obstructive pulmonary disease (COPD) [1-3]. Spirometry
testing is not only essential to confirm a diagnosis of ob-
structive lung disease, it also enables the general practi-
tioner (GP) to rule out airway obstruction in patients with
respiratory symptoms caused by other illnesses, such as
heart failure or lung cancer.
Despite international guidelines recommendations, we
confirmed that a large proportion of patients prescribed
medication targeting obstructive lung diseases do not
undergo spirometry testing [4]. Hence, these patients may
be medicated without having airway obstruction and ex-
posed to unnecessary economic costs and medication risks
[5,6]. More important, when spirometry is not performed,
patients may experience an unnecessary delay in the diag-
nostic process. In Denmark, the majority of patients with
respiratory symptoms are diagnosed and managed in gen-
eral practice. Spirometry has been shown to be both feas-
ible and reliable in general practice [7], but if preferred,
GPs can also refer patients to spirometry testing at hospi-
tals or outpatient clinics. Underutilisation of spirometry
when diagnosing obstructive lung disease is well known
[8-11]. Patient characteristics like age and gender have
been shown to influence spirometry testing [4,11,12] and
accuracy of diagnosis [13]. Also, some doctor and prac-
tice characteristics have been shown to influence spirom-
etry testing; unfamiliarity with conducting or interpreting
spirometry tests and spirometry being too time-consuming
are reported as barriers [14-17], and practice characteris-
tics like presence of a practice nurse and use of protocols
have been reported to enhance spirometry testing [15].
Rural differences in spirometry testing have also been
reported [18].
Studies have reported practice characteristics such as
practice size, organisation in partnership or single-handed
practices and having training practice status to influence
diagnosis and management of other illnesses [19-21].
Doctor characteristics like age and gender have also been
associated with different practice patterns [22,23]. How-
ever, we have not found studies assessing these factors
association with spirometry testing. Identifying practice
characteristics may have important implications for future
organisation of primary care services [24] and can help tar-
get interventions aiming to improve spirometry testing.
The aim of this study was therefore to examine if variation
in spirometry testing among patients receiving first-time
prescriptions for medication targeting obstructive lung dis-
ease is associated with specific practice characteristics.
Methods
A register-based cohort study covering the entire popu-
lation of 5.5 mill people and all general practices inDenmark (approx. 2400) was carried out. More than
98% of the population in Denmark is registered with a
general practitioner, who provides primary care services,
acts as a gatekeeper and refers patients to specialist care
when needed. The health care system in Denmark is tax
funded and patients have free access to all services re-
lated to general practice and hospital care, including spir-
ometry [25]. All general practices have direct access to
spirometry testing; either in their practice where the doc-
tors can conduct these tests themselves or have practice
staff conduct spirometry testing or the doctors can refer
patients to spirometry testing at hospitals or outpatient
clinics. From an earlier study we know that the majority
of spirometry tests conducted among new medication
users were performed in general practice [4].
All Danish citizens are registered in the Danish Civil
Registration System and assigned a unique personal identi-
fication number. Likewise, each general practice is also
assigned a unique identification number and these identifi-
cation numbers are used in all national registers, enabling
accurate linkage between patients, health care services and
general practice [26].
This study links several national registers all maintained
in Statistics Denmark, where researchers can apply for
access.
Study subjects
Patients were identified in the National Prescription
Register. We identified all adults who were first-time users
of medication targeting obstructive lung disease in 2008.
Firstly, all patients who redeemed medication targeting ob-
structive lung disease, defined as the anatomical thera-
peutic chemical (ATC) code R03 in 2008, were identified.
We then excluded patients who were either under 18 years
of age on 1 January 2008 or who had previous records of
prescriptions with ATC code R03 in the register (1995–
2007). All medication with ATC code R03 requires a pre-
scription and registration is therefore complete. For each
patient we identified whether they had redeemed R03
medication repeatedly within the first year and how
many types of R03 medication they initiated within this
first year. These two variables, “redeemed repeatedly”
and “number of therapies”, were used as proxies for
severity. Additionally, for each patient we retrieved 2008
data on socioeconomic and demographic status such as
age, gender, income, highest attained education, labour
market affiliation and cohabitation status.
Outcome - spirometry within the first year when
initiating medication
All spirometry measurements registered in the time period
2007–2009 were extracted from the National Health
Service Register, which covers primary care, and from
the National Patient Register, which covers hospitals and
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bases used for reimbursement and a prerequisite for
reimbursement is that all services conducted, including
spirometry testing, must be recorded in these registers.
For each patient we assessed if spirometry was registered
in an 18-month period counting from 6 months before to
12 months after the date of the first redemption of ob-
structive lung medication. All spirometric procedures were
included, irrespective of whether they were performed in
general practice, in an outpatient clinic, or in a hospital.
The results from the spirometry tests were not available in
the register.
General practice
All data on general practice were extracted from the
Danish National Health Service Provider Register. We
extracted data covering the period July 2007 – December
2009, corresponding to the absolute observation time of
the cohort. A total of 428 practices were omitted due to
missing data at the beginning or end of the time period, in-
dicating that these practices were established or closed in
this time period. A further 11 practices were omitted due
to a small list size (<500 patients), because these practices
are probably atypical and are not representative of general
practice. For each general practice we identified the num-
ber of established doctors registered at each practice. Doc-
tors not registered in the entire period were defined
temporary doctors and were not considered to be in the
established doctor group. Practices were defined single-
handed practices if only one established doctor was regis-
tered, and partnership practices if two or more established
doctors were registered. The majority of the temporary
doctors in general practice were junior doctors having six
months’ residency in practice, and practices with these
doctors listed in the time period were defined training
practices. The number of patients per doctor was defined
as the practice’s patient list size divided by the number of
established doctors. In single-handed practices the doctor’s
age and gender were extracted, in partnership practices we
calculated the mean age of the established doctor group
and assessed whether their gender was exclusively male or
female, predominantly male or female or equally mixed.
For each practice we calculated a “spirometry proportion”
defined as the proportion of adult patients within the prac-
tice receiving first-time prescriptions for medication
targeting obstructive lung disease who had spirometry
performed in the 18-month interval.
Statistical analysis
Practice characteristics are reported as categorical vari-
ables. For each practice characteristic we report the mean
and standard deviation of the “spirometry proportion”.
We used mixed effects logistic regression models with
patients nested within practice to calculate odds ratios(ORs) with 95% confidence intervals (CI) for the associa-
tions between practice characteristics and having spir-
ometry performed. We used two models. Model one
estimated the crude OR for each practice characteristic’s
association with spirometry testing, model two estimated
the OR for each practice characteristic, adjusted for both
patient characteristics and the other practice characteris-
tics included in the analysis. Our primary analysis was
model 2. Analyses comprised the entire cohort of general
practices and were subsequently stratified into single-
handed and partnership practices. This stratification was
done for two reasons: firstly, we hypothesised that this
important organisational factor could interact with other
practice characteristics, and secondly, some of the variables
like age and gender were average values in partnership
practices, but precise values in single-handed practices,
and separate analyses were needed. Patient characteristics
adjusted for were age, gender, income, highest attained
education, labour market affiliation, cohabitation status,
number of therapies initiated in the first years and repeat
prescription redemption. P-values < 0.05 were considered
statistically significant associations. Finally, we conducted
subgroup analyses of the association between practice
characteristics and spirometry testing among two different
subgroups of patients 1) patients over 45 years of age initi-
ating at least two types of medication and redeeming medi-
cation repeatedly and 2) patients less than 45 years of age
initiating only one type of medication. This was done to as-
sess if the associations shown among practice characteris-
tics in the overall group of patients receiving first-time
prescription for medication targeting obstructive lung dis-
ease were also present in 1) a subgroup of patients where
COPD is more common and 2) among younger patients
with mono therapy. We also repeated all analyses including
peak flow measurements conducted in the time period
as peak flow measurements might have been used in
asthma patients and this might influence some of associa-
tions seen.
All statistical analyses were carried out using STATA 11
(STATACorp, College Station, TX, USA).
Ethics
This project is register-based and according to “The Act
on Research Ethics Review of Health Research Projects in
Denmark” only questionnaire surveys and medical data-
base research projects involving human biological material
are required to be notified to the research ethics commit-
tee. The research ethics committee has, therefore, not been
contacted. The study was approved by the Danish Data
Protection Agency, J.nr. 2011-41-5798.
Results
A total of 1980 practices and 35 677 patients were in-
cluded in our analysis. Just about half of the patients had
Figure 1 Distribution of the spirometry proportion among general practice in total numbers (N=1980).
Table 1 Distribution of practice characteristics within the entire general practice cohort in absolute numbers (N); the
mean and standard deviation of the variable “spirometry proportion”* is reported for each practice characteristic
All general practices Single-handed practices Partnership practices
N Mean (SD) N Mean (SD) N Mean (SD)
Partnership practice Yes 773 54.4 (16.8) - - 773 54.4 (16.8)
No 1207 48.6 (22.7) 1207 48.6 (22.7) - -
Training practice Yes 566 53.7 (18.0) 239 53.8 (20.2) 327 53.7 (16.1)
No 1414 49.7 (21.8) 968 47.3 (23.2) 446 54.8 (17.3)
No of doctors 1 1207 48.6 (22.8) 1207 48.6 (22.8) - -
2 388 54.2 (18.7) - - 388 54.2 (18.7)
3 213 53.4 (15.6) - - 213 53.4 (15.6)
4 94 57.2 (13.2) - - 94 57.2 (13.2)
5 52 54.5 (14.2) - - 52 54.5 (14.2)
>5 23 55.0 (11.3) - - 23 55.0 (11.3)
Age
(mean for partnership practices) <45 106 56.0 (19.1) 67 52.2 (18.8) 39 62.5 (18.1)
45–49 238 55.8 (18.1) 122 54.5 (20.0) 116 57.2 (15,8)
50–54 516 54.2 (18.8) 228 52.4 (21.4) 288 55.7 (16.3)
55–59 609 49.7 (20.9) 366 48.3 (23.3) 243 51.7 (16.4)
60–64 390 46.4 (22.4) 314 45.9 (23.3) 76 50.4 (17.8)
>65 121 41.2 (23.9) 110 40.7 (24.3) 11 46.6 (−)
Gender Male 1017 49.4 (22.1) 873 48.7 (22.7) 144 53.4 (17.5)
Predominantly male 189 54.4 (15.0) - 189 54.4 (15.0)
Equal male/female 283 54.9 (18.6) - 283 54.9 (18.6)
Predominantly female 98 54.3 (13.6) - 98 54.3 (13.6)
Female 393 49.2 (22.3) 334 48.3 (23.0) 59 54.0 (17.1)
Patients per doctor <1347 513 49.8 (22.8) 227 43.9 (21.8) 286 54.4 (18.2)
1347–1575 489 51.0 (19.8) 277 49.1 (21.8) 212 53.5 (16.4)
1576–1756 489 52.3 (20.8) 307 49.9 (23.4) 182 56.5 (14.6)
>1756 489 50.3 (19.7) 396 49.9 (20.3) 93 51.9 (17.0)
*The “spirometry proportion” is defined as the proportion of adult patients within the practice receiving first-time prescriptions for medication targeting obstructive
lung disease who had spirometry performed in the 18-month interval.
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Table 3 Association between practice characteristics and
spirometry testing in partnership practices
Model 1 Model 2**
Crude OR Adjusted OR
(95% CI) (95% CI)
Training practice
No 1 1
Yes 0.95 (0.84–1.08) 0.91 (0.79–1.04)
Mean age of doctors (years)
≤ 45 1 1
45–49 0.72 (0.50–1.03) 0.66 (0.45–0.97)*
50–54 0.68 (0.47–0.98)* 0.61 (0.42–0.89)*
55–59 0.54 (0.34–0.86)* 0.45 (0.29–0.71)*
60–64 0.52 (0.31–0.86)* 0.43 (0.26–0.72)*
≥65 0.39 (0.17–0.90)* 0.25 (0.10–0.61)*
Number of doctors
2 1 1
3 0.97 (0.84–1.13) 0.99 (0.77–1.27)
4 1.17 (0.95–1.45) 1.15 (0.90–1.45)
5 1.03 (0.82–1.30) 1.08 (0.77–1.51)
>5 1.05 (0.76–1.37) 1.03 (0.69–1.53)
Number of patients per doctor
<1347 1 1
1347–1575 0.96 (0.82–1.12) 0.97 (0.82–1.15)
1576–1756 1.12 (0.94–1.34) 1.16 (0.96–1.34)
>1756 0.86 (0.69–1.07) 0.88 (0.70–1.11)
Gender of doctors
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to 51.2% (18 263/35 677). Among general practices, the
mean “spirometry proportion” was 50.8%. The distribu-
tion of the “spirometry proportion” among general prac-
tice is illustrated in Figure 1 and it demonstrates quite a
large variation between practices. An overview of practice
characteristics and their mean “spirometry proportion” is
shown in Table 1.
When comparing all general practices, partnership
practices had a higher OR of performing spirometry
compared with single-handed practices (OR 1.24, CI
1.09-1.40), Table 2. In all analyses we saw that increasing
age among the group of established doctors decreased
the odds of spirometry testing; in the analysis comparing
all practices, the smallest OR was seen among doctors
over 65 years (OR 0.33, CI 0.22-0.50). The most pro-
nounced effect of doctors’ increasing age on spirom-
etry was seen among partnership practices (OR 0.25,
CI 0.10-0.61), Table 3. A test for trend showed a significant
association between increasing GP age and decreasing spir-
ometry testing. Being a training practice was significantly
associated with spirometry testing among single-handed
practices (OR 1.40, CI 1.10-1.79), Table 4. There was no
significant association between the doctors’ gender or
number of patients per doctor and having spirometry
performed. Further, there was no significant association be-
tween number of doctors in a partnership practice and
having spirometry performed. Both subgroup analyses
demonstrated the same tendency in associations: an in-
creased OR for spirometry testing was seen among part-
nership practices, practices with younger doctors andMale 1 1
Predominantly male 1.05 (0.87–1.27) 0.99 (0.77–1.27)
Equal male/female 1.07 (0.89–1.29) 1.04 (0.85–1.28)
Predominantly female 1.05 (0.84–1.32) 0.94 (0.73–1.26)
Female 1.07 (0.81–1.42) 1.04 (0.76–1.42)
*P-value< 0.05 **Adjusted for patient factors and practice characteristics.
Table 2 Association between practice characteristics and
spirometry testing among all practices
Model 1 Model 2**
Crude OR Adjusted OR
(95% CI) (95% CI)
Training practice
No 1 1
Yes 1.20 (1.06–1.36)* 1.10 (0.97–1.25)
Single-handed practice
Yes 1 1
No 1.34 (1.16–1.55)* 1.24 (1.09–1.40)*
Mean age of doctors (years)
≤ 45 1 1
45–49 0.94 (0.74–1.19) 0.87 (0.66–1.14)
50–54 0.88 (0.70–1.09) 0.78 (0.60–1.00)
55–59 0.68 (0.53–0.87)* 0.58 (0.44–0.76)*
60–64 0.58 (0.43–0.79)* 0.52 (0.39–0.70)*
≥65 0.41 (0.27–0.64)* 0.33 (0.22–0.50)*
*P-value< 0.05 **Adjusted for patient factors and practice characteristics.among single-handed practices with training practice
status (data not shown). These associations were how-
ever, only statistically significant among patients over
45 years of age initiating at least two types of medication
and redeeming medication repeatedly. Adding peak flow




This study demonstrated that patients receiving first-
time prescriptions for medication targeting obstructive
lung disease had higher odds of having spirometry
performed if their general practice was a partnership
practice. All analysis confirmed decreasing spirometry
Table 4 Association between practice characteristics and
spirometry testing in single-handed practices
Model 1 Model 2**
Crude OR Adjusted OR
(95% CI) (95% CI)
Training practice
No 1 1
Yes 1.40 (1.06–1.87)* 1.40 (1.10–1.79)*
Age of doctor (years)
≤ 45 1 1
45–49 1.11 (0.78–1.58) 1.09 (0.73–1.61)
50–54 0.99 (0.78–1.58) 0.96 (0.67–1.38)
55–59 0.79 (0.73–1.35) 0.71 (0.49–1.03)
60–64 0.69 (0.56–1.10) 0.64 (0.43–0.95)*
≥65 0.50 (0.28–0.89)* 0.44 (0.28–0.76)*
Number of patients
<1347 1 1
1347–1575 1.29 (0.97–1.71) 1.26 (0.95–1.67)
1576–1756 1.30 (0.99–1.72) 1.21 (0.92–1.59)
>1756 1.35 (1.02–1.79)* 1.17 (0.90–1.51)
Gender of doctor
Male 1 1
Female 0.98 (0.84–1.15) 0.93 (0.77–1.12)
*P-value< 0.05 **Adjusted for patient factors and practice characteristics.
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handed practices, training practice status was associated
with increased spirometry testing. These associations all
had an OR above 1.23 or below 0.67 and were considered
relevant associations.
Strengths and limitations of this study
The register-based design has the major strength that
it allows us to include the entire population and all
established general practices in Denmark. The validity of
the data in these national registries is considered high, as
they are based on administrative data used for reimburse-
ment in the health care system [27]. Due to this economic
incentive, spirometry recording is quite complete, although
a slight under- or over-recording cannot be entirely ex-
cluded. The low rate of spirometry testing is therefore
mainly due to non-use and not to inconsistent recording.
The registers do, however, not contain data on how the
spirometry was conducted, and we cannot exclude some
variation in the quality of these measurements.
The registries enable accurate linkage of detailed infor-
mation on each practice and patient and make it pos-
sible to adjust for numerous patient factors, enhancing
the possibility of isolating and assessing practice charac-
teristics’ influence on spirometry testing in our cohort.Nonetheless, it is important to remember that influence
of patient characteristics cannot be entirely excluded;
the registers cannot provide complete information on all
sociodemographic patient characteristics.
Another challenge was that patient data could only be
linked on the level of general practice, preventing us
from identifying the doctor within the practice who is
primarily responsible for each patient. This complicates
the assessment of the influence of doctors’ age and gen-
der on spirometry testing when dealing with partnership
practices. Mean age of established doctors is a compromise
and is not as informative as an individual doctor’s age.
Also, “patients per doctor”, a proxy for workload, may be
inaccurate, as doctors in Denmark can schedule their own
work. General practitioners with few listed patients may
work part-time and still have a high workload in practice.
Newly established and closing practices were excluded
in these analyses, and it is important to remember that
our data underrepresent these practices, but this was
done deliberately. Firstly, forming and closing practices
were quite unstable in the time period with regard to both
number of doctors and number of patients, making cat-
egorisation quite difficult, and secondly, we hypothesised
that forming and closing practices could confound our
results in favour of larger practices.
Other potential influential variables could have been
interesting to include in our study if they were available
in our databases. The presence of a practice nurse and
the practice’s location (rural or urban area, distance to
outpatient clinics) could influence spirometry testing
and were very relevant to include in our study. However,
the registers contain no data on employed staff in gen-
eral practice, and the limited data on practice location
were not adequate for assessing either rural or urban lo-
cation or distance to relevant outpatient clinics.
Interpretation of findings in relation to previously
published work
Two studies tested if quality of care scores in asthma pa-
tients were influenced by practice size, but found no asso-
ciation [28,29]. Other studies have found single-handed
practices and small practice size to be associated with in-
creased acute admission rates to hospitals for asthma, but
not for COPD [30,31]. Our measure for practice size was
divided into two variables: number of doctors and number
of patients per doctor. When looking solely at the number
of doctors, we found that single-handed practices had
lower odds of performing spirometry compared to partner-
ship practices in concordance with the above mentioned
studies. Among partnership practices, however, there was
no association between number of doctors and odds of
spirometry testing, indicating that size of partnership prac-
tices was not associated with spirometry testing. Further,
we found no association between number of patients per
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tices and larger practices have been associated with higher
scores for quality of care in several chronic diseases
[19,20], studies are not consistent with regard to this issue,
as the opposite has also been shown [32], and it is interest-
ing that patient satisfaction has been reported to be in
favour of single-handed practices [33,34].
Increasing age among doctors has been reported to be
associated with decreasing quality of care scores in stud-
ies [35,36] and these findings are in concordance with
our study, where we found a clear tendency between in-
creasing age and decreasing OR for spirometry testing.
Our study does not clarify why older doctors perform
fewer spirometry tests in patients initiating medication,
but general practitioners’ age has been shown to influ-
ence clinical practice patterns, with older GPs providing
more home visits, doing fewer procedures and having
higher prescribing rates [22]. We found no association
between GP gender and spirometry testing. Other stud-
ies have reported that when assessing quality scores, fe-
male physicians are more often among high scorers and
the majority of the lowest scoring physicians are men
[35,37]. Specifically, female GPs have been reported to
attain higher scores in evaluation of antenatal care and
more often refer to bone mineral density testing [23,38].
We therefore hypothesised that female GPs performed
more tests as shown by Ioannidis et al. [23], but our data
showed no indication of this pattern.
Training practices have also been shown to influence
quality of care [19,35] and in our study we also saw this
tendency, but only among single-handed practices. Why
training practice status influences single-handed prac-
tices, but not partnership practices, is unknown, but we
suggest that this difference in effect is due to a greater
interaction between the single-handed practitioner and
the resident doctor compared to the interaction seen in
a partnership practice with several doctors.
Overall, we conclude that the variation in spirometry
testing between practices was quite large and some of
this variation can be associated with practice characteris-
tics. Concluding whether the variation shown in spirom-
etry testing is due to a variation in quality of care is
more challenging. Although spirometry is essential for
diagnosing obstructive lung disease and could therefore
be used as a marker of good quality, it may not be rele-
vant for all patients receiving first-time prescriptions for
medication targeting obstructive lung disease to have
spirometry performed. Among some patients it may be
clinically meaningful not to conduct spirometry testing,
for example among patients who are unable to corporate
sufficiently. However, the variations shown could indi-
cate a potential room for quality improvement and fur-
ther studies should be conducted to clarify this issue.
Also, assessing changes in spirometry testing over timein general practice would be relevant, as improvements
have been seen in outpatient clinics in recent years [39].
Conclusions
Some of the variations in the frequency of spirometry test-
ing are associated with practice characteristics. Young age
among doctors, being a partnership practice, or if a single-
handed practice, being a training practice, were all factors
associated with increased odds of performing spirometry
when patients receive first-time prescriptions for medica-
tion targeting obstructive lung disease.
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